AI-generated analysis. Always verify with the original filing.
Voyager Therapeutics, Inc. filed an 8-K on March 9, 2026, under Item 2.02 with Exhibit 99.1 furnished, indicating results of operations or earnings disclosure. Item 2.02 and Exhibit 99.1 are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am
. Financial Statements and Exhibits (d) Exhibits The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: Exhibit N